Christine Bahls


Key Guidance Updates in 2022

December 02, 2022

Summarizing important FDA and EMA revisions issued this year.

The Implications of Inflation for Drug Development

November 10, 2022

Experts gauge threat level for global trials amid staffing and funding issues.

The Risk-Reward Proposition for CGT Clinical Trials

October 14, 2022

As activity in this space grows, so do the hurdles in moving these products forward.

‘Record’ Gains in Bringing Research Closer to the Patient

September 07, 2022

Experts discuss solving the EHR-compatibility puzzle in point-of-care trials.

The Evolution of Site Selection

October 13, 2021

New support models range from flexible software platforms, IROs, and DROs.

The Post-Pandemic CRO Landscape

September 08, 2021

Technology, talent and specialization add up to a plethora of industry M&As.